The Effects of Adding Dexamethasone in the Quadratus Lumborum Block
NCT ID: NCT04496193
Last Updated: 2020-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
90 participants
INTERVENTIONAL
2020-07-31
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Dexamethasone is a synthetic corticosteroid for the treatment of a wide range of symptoms including rheumatic diseases, certain skin diseases, severe allergies, asthma, chronic obstructive pulmonary disease, cerebral edema, and may also be combined with antibiotics for tuberculosis patients. It is becoming more common to use steroids as an adjuvant to local anesthetics in peripheral nerve block. Steroids have neurological blockade effects by blocking the nociceptive transmission of pith-type C-fibers and inhibiting the release of ectopic neurons. Dexamethasone, as a local anesthetic adjuvant in peripheral nerve block, has also been widely studied recently.
In order to reduce the incidence of long-acting topical anesthetics from the nerve block in the quadratus lumborum block, reducing the local anesthetic concentration is a feasible method. However, this will also result in a shorter time to neurological block. The investigators hypothesized that the addition of Dexamethasone 5 mg to low concentrations (0.25%) of Ropivacaine would prolong postoperative analgesia. Therefore, the purpose of this study was to compare the postoperative analgesia and the side effects of postoperative quadratus lumborum block with the addition of Dexamethasone 4mg to Ropivacaine (0.25%) in low concentrations and Ropivacaine (0.5%) alone.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transmucular Quadratus Lumborum Block: Potential Quadriceps Muscle Weakness
NCT05023343
Dexamethasone Versus Demedetomidine Addition for Adductor Canal Block
NCT06527976
Nerve Blocks With Dexamethasone and Local Anaesthetic to Improve Postoperative Analgesia
NCT02436694
Analgesic Effect of Adductor Canal Block With and Without Dexamethasone for Knee Arthroscopy
NCT03239314
Dexamethasone as an Adjuvant to Ropivacaine for the Interscalene Brachial Plexus Block
NCT02818491
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Name: Dexamethasone sod. Phosphate
2. Dosage form: 5 milligram (mg)/1 milliliter (mL)/Amp
3. Dose(s): 4mg
4. Dosing schedule: Dexamethasone 4mg adds into 0.25% Ropivacaine 20 mL
5. Mechanism of action: Synthesis of adrenocortical hormones, has a strong anti-inflammatory effect, can prolong the effect of local anesthetic drugs
6. Pharmacological category: HS051 Glucocorticoids
Study design:
1\. ☑ Control: ☑ placebo(N/S 0.8 mL + 0.25% Ropivacaine 20 mL)
* active (Dexamethasone 4mg+0.25% Ropivacaine 20 mL)
* others(N/S 0.8 mL + 0. 5% Ropivacaine 20 mL) □ Uncontrolled 2. Blinding: □ open-label □ single blind ☑ double blind □ others 3. Randomized: ☑ yes □ no 4. ☑ Parallel □ cross-over □ others 5. Duration of study:from Institutional Review Board (IRB) approval \~to 12, 31, 2022 ,total 24 months Duration of Enrollment : from IRB approval \~to 12, 31, 2022 ,total 24 months Duration of treatment:from IRB approval \~to 12, 31, 2022 ,total 24 months Duration of follow-up: from IRB approval \~to 12, 31, 2022 ,total 24 months
* Multi-national □multi-center(Taiwan) ☑single center(Taiwan) 6. Number of subjects: 90 7. Is there any of the followings included Data Safety and Monitoring Board (DSMB)
* yes ☑ no
Assessment criteria:
1\. Efficacy:
1. The intensity of pain was assessed using a 0 to 10 Numerical Rating Scale (NRS) to quantify their degree of pain; where 0 means no pain and 10 the worst pain imaginable.
2. The analgesic activity was assessed using standard measures during the 48-hour treatment period: baseline pain intensity, time to rescue medication, and overall patient evaluation of study medication.
2\. Safety:
1. Record the hemodynamic parameters during the 60-minute observation period in the anesthesia recovery room.
2. The severity of postoperative side effects (nausea, vomiting, pruritus) was quantified using different scales. Other side effects, including dizziness and drowsiness, are also recorded.
3. Motor block is assessed using Modified Bromage Scale.
3\. Pharmacokinetics: None
4\. Quality of life:
1. analgesic activity and duration of action
2. patient satisfaction
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group lower dose ropivacaine with dexamethasone
Quadratus lumborum block was administered with 0.25% Ropivacaine 20 ml + dexamethasone 0.8 ml (4mg) at the end of surgery
Quadratus Lumborum block
Quadratus Lumborum block is a type of plane block where local anesthetic is injected adjacent to the quadratus lumborum muscle with the goal of anesthetizing the thoracolumbar nerves.
Group higher dose ropivacaine with N/S
Quadratus lumborum block was administered with 0.5% Ropivacaine 20 ml + N/S 0.8 ml at the end of surgery
Quadratus Lumborum block
Quadratus Lumborum block is a type of plane block where local anesthetic is injected adjacent to the quadratus lumborum muscle with the goal of anesthetizing the thoracolumbar nerves.
Group lower dose ropivacaine with N/S
Quadratus lumborum block was administered with 0.25% Ropivacaine 20 ml + N/S 0.8 ml at the end of surgery
Quadratus Lumborum block
Quadratus Lumborum block is a type of plane block where local anesthetic is injected adjacent to the quadratus lumborum muscle with the goal of anesthetizing the thoracolumbar nerves.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quadratus Lumborum block
Quadratus Lumborum block is a type of plane block where local anesthetic is injected adjacent to the quadratus lumborum muscle with the goal of anesthetizing the thoracolumbar nerves.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who received quadratus lumborum block for post-hip surgery analgesia
Exclusion Criteria
* Coagulation abnormalities with international normalized ratio (INR) \> 1.5
* Obvious heart, lung, liver or kidney disease
* Body mass index less than 18.5 or greater than 35
* Pregnancy
* Regular use of steroids or opiates Opioids
* Chronic medication or alcohol abuse
* Previous allergies or adverse reactions to opiates, dexamethasone, or ropivacaine
20 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaohsiung Medical University Chung-Ho Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hung-Te Hsu, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Anesthesiology, Kaohsiung Medical University Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KMUHIRB-F(I)-20200099
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.